drugset / Trial / NCT07294326

A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis Symptoms

NCT07294326

Phase 4 Not yet recruiting 50 enrolled China-Japan Union Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Through prospective exploration of the efficacy of intranasal corticosteroids (INCS) combined with intranasal antihistamines (INAH) and INCS combined with oral antihistamines (OAH) in treating moderate to severe allergic rhinitis symptoms, this study aims to provide evidence-based medical evidence for the standardized treatment of patients with moderate to severe allergic rhinitis accompanied by typical nasal and ocular symptoms.

Timeline

Start
2026-01-01
Primary completion
2026-10-31
Completion
2026-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azlastine hydrochloride Unknown 137 ug Oral
Comparator Azlastine hydrochloride Unknown 2 mg Oral
Comparator Fluticasone propionate Other / unclassified 50 ug Intranasal

Indications